Home | Sitemap | Contact | Directory | CAS | 中文
Search: 
About Us News People Research Education & Training International Cooperation Societies & Publications Papers Resources Links Join Us
 
原网站信息
include
search
About us
Research
People
International Cooperation
News
Resources
Education & Training
Join Us
Societies & Publications
Papers
Links
Sitemap
  Location: home>原网站信息
IMCAS and Japan’s DNAVEC Partner on AIV Vaccine Research
Author:        Updatetime:2008-05-06 Printer      Text Size:A A A 


The Institute of Microbiology and Japan’s DNAVEC Corporation signed an agreement on April 1, 2008 in Beijing to conduct a joint preclinical research on avian influenza viruse (AIV) vaccines. Avian influenza is an infection caused by avian influenza viruses. Outbreaks of highly pathogenic avian influenza associated with illness and death in humans have occurred in Asia since late 2003. Some virus strains have evolved to become more deadly and be able to infect more species. This situation has attracted more and more concern throughout the world. The collaborative research between IMCAS and DNAVEC may shed new light to the prevention of avian influenza pandemic.
 
Back Article:Introduction      Next Article: Aim
Institute Of Microbiology Chinese Academy of Sciences
NO.1 West Beichen Road, Chaoyang District, Beijing 100101, China Phone: 0086-10-64807462 Fax: 0086-10-64807468 Email: office@im.ac.cn